Aethlon Medical Enters Merger Agreement With North Immunology
Aethlon Medical entered a merger agreement with North Immunology on Sept. 17, 2026; the deal is not assured. The company has treated eight patients in its Phase 1 oncology study and intends to conclude recruitment in connection with the merger.
Aethlon entered a merger agreement with North Immunology on Sept. 17, 2026; the deal is not assured. Aethlon has treated eight patients in its Phase 1 oncology study and intends to conclude recruitment in connection with the merger.Material DetailsContext by AI AnalystThis is a significant transact…